A Study of Nanrilkefusp Alfa (SOT101) in Combination With Cetuximab to Evaluate the Efficacy and Safety in Patients With Colorectal Cancer
Clinical trial NCT05619172 · TERMINATED
Trial details
- NCT number
- NCT05619172
- Sponsor
- SOTIO Biotech AG
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-22
- Primary completion
- 2024-03-06
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.